In today’s biotechnology and pharmaceutical landscape, nano lipid particles (LNPs) have become a cornerstone of next-generation drug delivery. From mRNA vaccines to gene editing platforms, these nanoscale carriers are transforming how therapeutic agents are transported and released at the cellular level. As the industry shifts toward precision medicine, companies like XGen Bio are...